+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Plasma Fractionation Market - Global Forecast 2026-2032- Product Image
Plasma Fractionation Market - Global Forecast 2026-2032- Product Image
New

Plasma Fractionation Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 180 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5336507
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The plasma fractionation market is evolving rapidly, driven by innovation in processing technologies, shifting clinical requirements, and dynamic regulatory environments. Senior decision-makers must navigate this landscape with clarity to seize opportunity, manage risk, and sustain supply chains in a sector fundamental to modern healthcare delivery.

Market Snapshot: Plasma Fractionation Market Size and Growth

The Plasma Fractionation Market grew from USD 40.22 billion in 2025 to USD 44.05 billion in 2026. It is expected to continue growing at a CAGR of 9.97%, reaching USD 78.28 billion by 2032. This market expansion reflects robust clinical demand, advances in purification techniques, and increasing adoption of plasma-derived therapies globally. As life science innovation integrates with complex logistics, the sector remains vital for blood-based therapeutics used in diverse specialties.

Scope & Segmentation of the Plasma Fractionation Market

This analysis offers a comprehensive view across products, methodologies, applications, and end-user segments, enabling clear strategic direction. Major segmentation areas include:

  • Product Types: Albumin, Coagulation Factor Concentrates, Immunoglobulins (intravenous, subcutaneous), Protease Inhibitors
  • Fractionation Methods: Centrifugation, Cryoprecipitation, Ethanol Precipitation, Ion-Exchange Chromatography, Ultrafiltration
  • Clinical Applications: Hematology, Neurology, Oncology, Rheumatology
  • End-Users: Academic Institutions, Clinical Research Laboratories, Hospitals, Clinics
  • Regions Covered: Americas, Europe, Middle East & Africa, Asia-Pacific

Each segment reveals distinct market drivers and operational challenges. For example, uptake of subcutaneous immunoglobulin is shaping home healthcare models, while demand for coagulation factors emphasizes supply chain rigor and clinical education.

Key Takeaways: Strategic Insights for Plasma Fractionation Leadership

  • Product and technology diversification is accelerating, with recent advances supporting continuous processing and heightened product consistency.
  • Regulatory modernization places increased importance on traceability, donor safety, and supply resilience, driving investments in new screening and monitoring systems.
  • Competitive strategies emphasize modular manufacturing and data-driven operations, enabling rapid response to evolving clinical and policy demands.
  • Clinical demand in areas such as neurology and oncology is influencing manufacturing priorities, particularly for immunoglobulin and coagulation therapies.
  • Collaboration between biopharma, fractionators, and academic centers is streamlining the path from innovation to market by supporting translational research and multi-disciplinary pipelines.
  • Talent in bioprocess engineering, quality systems, and regulatory affairs remains a critical differentiator in navigating complex approval and commercialization pathways.

Tariff Impact on Plasma Fractionation Supply Chains

Recent United States tariff measures have raised input costs for imported raw materials and critical components, prompting manufacturers to localize procurement or renegotiate long-term supply contracts. These policies have intensified manufacturing footprint decisions, as organizations weigh shifting production or investing in regional sourcing to manage regulatory and financial risks. Downstream, hospitals and clinics are adjusting procurement and inventory management to offset increased costs and supply variability, emphasizing the need for diversified supplier strategies and strategic inventory buffers to maintain continuity of patient care.

Methodology & Data Sources

This report integrates structured executive interviews, peer-reviewed research, regulatory analysis, and technical whitepapers. Scenario testing and expert peer reviews enhance reliability, ensuring that recommendations reflect practical realities for plasma fractionators, suppliers, and clinical stakeholders.

Why This Report Matters

  • Enables senior leaders to align manufacturing operations with future clinical and regulatory shifts.
  • Supports informed capital and procurement planning in an increasingly complex, globalized healthcare landscape.
  • Delivers actionable segmentation and supply-chain insight to optimize resilience and competitive position.

Conclusion

Plasma fractionation leaders who invest in manufacturing flexibility, build robust supply partnerships, and adapt regionally will be best equipped to support clinical innovation and sustain operational stability. Forward-looking strategies informed by this analysis position organizations to meet shifting demand and policy expectations.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Plasma Fractionation Market, by Product Type
8.1. Albumin
8.2. Coagulation Factor Concentrates
8.3. Immunoglobulins
8.3.1. Intravenous Immunoglobulin
8.3.2. Subcutaneous Immunoglobulin
8.4. Protease Inhibitors
9. Plasma Fractionation Market, by Method of Fractionation
9.1. Centrifugation
9.2. Cryoprecipitation
9.3. Ethanol Precipitation
9.4. Ion-Exchange Chromatography
9.5. Ultrafiltration
10. Plasma Fractionation Market, by Application
10.1. Hematology
10.2. Neurology
10.3. Oncology
10.4. Rheumatology
11. Plasma Fractionation Market, by End-User
11.1. Academic Institutions
11.2. Clinical Research Laboratories
11.3. Hospitals & Clinics
12. Plasma Fractionation Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Plasma Fractionation Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Plasma Fractionation Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Plasma Fractionation Market
16. China Plasma Fractionation Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. 3M Company
17.6. ADMA Biologics, Inc.
17.7. Bharat Serums and Vaccines Limited
17.8. Biotest AG by Grifols, S.A.
17.9. China Biologic Products, Inc.
17.10. CSL Limited
17.11. Emergent BioSolutions Inc.
17.12. GC Biopharma corp.
17.13. HEINKEL Process Technology GmbH
17.14. Hemarus Therapeutics Ltd
17.15. Intas Pharmaceuticals Ltd.
17.16. Kamada Ltd.
17.17. Kedrion S.p.A.
17.18. LFB SA
17.19. Merck KGaA
17.20. Octapharma AG
17.21. PlasmaGen BioSciences Pvt. Ltd.
17.22. Prothya Biosolutions B.V.
17.23. Shanghai Raas Blood Products Co. Ltd.
17.24. SK Plasma Co.,Ltd.
17.25. STERIS plc
17.26. Takeda Pharmaceutical Company Ltd.
List of Figures
FIGURE 1. GLOBAL PLASMA FRACTIONATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL PLASMA FRACTIONATION MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL PLASMA FRACTIONATION MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA PLASMA FRACTIONATION MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL PLASMA FRACTIONATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ALBUMIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ALBUMIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PROTEASE INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PROTEASE INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY PROTEASE INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CENTRIFUGATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CENTRIFUGATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CENTRIFUGATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CRYOPRECIPITATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CRYOPRECIPITATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CRYOPRECIPITATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ETHANOL PRECIPITATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ETHANOL PRECIPITATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ETHANOL PRECIPITATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ION-EXCHANGE CHROMATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ION-EXCHANGE CHROMATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ION-EXCHANGE CHROMATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ULTRAFILTRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ULTRAFILTRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ULTRAFILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY RHEUMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY RHEUMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY RHEUMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CLINICAL RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CLINICAL RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY CLINICAL RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 63. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 64. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 65. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2032 (USD MILLION)
TABLE 66. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 67. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 68. NORTH AMERICA PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. NORTH AMERICA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 70. NORTH AMERICA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 71. NORTH AMERICA PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2032 (USD MILLION)
TABLE 72. NORTH AMERICA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 73. NORTH AMERICA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 74. LATIN AMERICA PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. LATIN AMERICA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 76. LATIN AMERICA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 77. LATIN AMERICA PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2032 (USD MILLION)
TABLE 78. LATIN AMERICA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 79. LATIN AMERICA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2032 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 86. EUROPE PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. EUROPE PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 88. EUROPE PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 89. EUROPE PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2032 (USD MILLION)
TABLE 90. EUROPE PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 91. EUROPE PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 92. MIDDLE EAST PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. MIDDLE EAST PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 94. MIDDLE EAST PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 95. MIDDLE EAST PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2032 (USD MILLION)
TABLE 96. MIDDLE EAST PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 97. MIDDLE EAST PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 98. AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. AFRICA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 100. AFRICA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 101. AFRICA PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2032 (USD MILLION)
TABLE 102. AFRICA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 103. AFRICA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. ASEAN PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. ASEAN PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 113. ASEAN PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 114. ASEAN PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2032 (USD MILLION)
TABLE 115. ASEAN PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 116. ASEAN PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 117. GCC PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GCC PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 119. GCC PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 120. GCC PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2032 (USD MILLION)
TABLE 121. GCC PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 122. GCC PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 123. EUROPEAN UNION PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. EUROPEAN UNION PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 125. EUROPEAN UNION PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 126. EUROPEAN UNION PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2032 (USD MILLION)
TABLE 127. EUROPEAN UNION PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 128. EUROPEAN UNION PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 129. BRICS PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. BRICS PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 131. BRICS PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 132. BRICS PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2032 (USD MILLION)
TABLE 133. BRICS PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 134. BRICS PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 135. G7 PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. G7 PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 137. G7 PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 138. G7 PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2032 (USD MILLION)
TABLE 139. G7 PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 140. G7 PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 141. NATO PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. NATO PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 143. NATO PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 144. NATO PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2032 (USD MILLION)
TABLE 145. NATO PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 146. NATO PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 149. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 150. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 151. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2032 (USD MILLION)
TABLE 152. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 153. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 154. CHINA PLASMA FRACTIONATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 155. CHINA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 156. CHINA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2032 (USD MILLION)
TABLE 157. CHINA PLASMA FRACTIONATION MARKET SIZE, BY METHOD OF FRACTIONATION, 2018-2032 (USD MILLION)
TABLE 158. CHINA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 159. CHINA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Plasma Fractionation market report include:
  • 3M Company
  • ADMA Biologics, Inc.
  • Bharat Serums and Vaccines Limited
  • Biotest AG by Grifols, S.A.
  • China Biologic Products, Inc.
  • CSL Limited
  • Emergent BioSolutions Inc.
  • GC Biopharma corp.
  • HEINKEL Process Technology GmbH
  • Hemarus Therapeutics Ltd
  • Intas Pharmaceuticals Ltd.
  • Kamada Ltd.
  • Kedrion S.p.A.
  • LFB SA
  • Merck KGaA
  • Octapharma AG
  • PlasmaGen BioSciences Pvt. Ltd.
  • Prothya Biosolutions B.V.
  • Shanghai Raas Blood Products Co. Ltd.
  • SK Plasma Co.,Ltd.
  • STERIS plc
  • Takeda Pharmaceutical Company Ltd.

Table Information

Report AttributeDetails
No. of Pages180
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 44.05 Billion
Forecasted Market Value ( USD ) by 2032 $ 78.28 Billion
Compound Annual Growth Rate9.9%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Plasma Fractionation Market Report by Product, Sector, Application, End User, and Region 2025-2033 - Product Image

Plasma Fractionation Market Report by Product, Sector, Application, End User, and Region 2025-2033

  • Report
  • 137 Pages
  • Global
From
Plasma Fractionation Market 2025-2029 - Product Image

Plasma Fractionation Market 2025-2029

  • Report
  • 214 Pages
  • Global
From
Plasma Fractionation Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Plasma Fractionation Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 140 Pages
  • Global
From
Plasma Fractionation Market Report 2025 - Product Image

Plasma Fractionation Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Plasma Fractionation Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Plasma Fractionation Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From

About the Plasma Fractionation Market

The Plasma Fractionation market is a subset of the Blood Banking industry, which involves the collection, processing, and distribution of human blood and its components. Plasma fractionation is the process of separating plasma from whole blood, which is then used to produce a variety of therapeutic proteins and other products. These products are used to treat a variety of conditions, including hemophilia, immune deficiencies, and other rare diseases. Plasma fractionation also plays an important role in the production of vaccines and other biopharmaceuticals. The Plasma Fractionation market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include CSL Behring, Grifols, Octapharma, Kedrion, and Biotest. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.